RY 176.35 -0.3841% SHOP 167.99 -0.7151% TD 82.75 0.2544% ENB 64.05 0.0% BN 88.32 1.6107% TRI 241.54 0.9909% CNQ 44.115 0.7652% CP 113.63 -0.342% CNR 151.81 0.2774% BMO 145.19 0.408% BNS 75.07 -0.0399% CSU 4740.3501 0.4989% CM 92.68 -0.2368% MFC 43.88 0.9664% ATD 75.94 0.0132% NGT 59.47 -0.1008% TRP 65.46 0.2911% SU 55.67 1.0895% WCN 263.59 0.0835% L 185.08 0.3198%
DexCom, Inc
DexCom, Inc. (NASDAQ: DXCM) is a medical device company specializing in continuous glucose monitoring (CGM) systems. It empowers individuals to manage their health in real-time and focuses on advancing diabetes care technology. By addressing the needs of patients, caregivers, and healthcare providers, DexCom strives to simplify and enhance diabetes management globally. The company's primary mission is to design, develop, and commercialize CGM systems to support diabetes management for users, their support networks, and clinicians worldwide.
As per our previous Kalkine’s American Tech Report on ‘DXCM’ on 26th November 2024, Kalkine provided an ‘Buy’ stance on the stock at USD 77.83 based on technical analysis and the stock price has now moved by ~13.02% since then and has breached resistance 1.
Noted below are the details of support and resistance levels provided in our previous report:
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
CA 
AU
UK
US
NZ
Please wait processing your request...